The Nrf2 signaling cascade is considered a double-edged sword in that, to exert chemotherapeutic activities, Nrf2 needs to be downregulated while to prevent cancer recurrence, Nrf2 cascade needs to be upregulated. This evidence concerns the gene NFE2L2 and cancer.